Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Molecular breakpoint cloning and gene expression studies of a novel translocation t(4;15)(q27;q11.2) associated with Prader-Willi syndrome.

Tytuł:
Molecular breakpoint cloning and gene expression studies of a novel translocation t(4;15)(q27;q11.2) associated with Prader-Willi syndrome.
Autorzy:
Schüle B; Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA. />Albalwi M
Northrop E
Francis DI
Rowell M
Slater HR
Gardner RJ
Francke U
Źródło:
BMC medical genetics [BMC Med Genet] 2005 May 06; Vol. 6, pp. 18. Date of Electronic Publication: 2005 May 06.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
Język:
English
Imprint Name(s):
Original Publication: London : BioMed Central, [2000-
MeSH Terms:
Chromosome Breakage/*genetics
Chromosomes, Human, Pair 15/*genetics
Chromosomes, Human, Pair 4/*genetics
Cloning, Molecular/*methods
Gene Expression Regulation/*genetics
Prader-Willi Syndrome/*genetics
Translocation, Genetic/*genetics
Adult ; Antigens, Neoplasm ; Autoantigens ; Blotting, Southern/methods ; Chromosome Mapping/methods ; Cytogenetic Analysis/methods ; DNA Methylation ; Expressed Sequence Tags ; Humans ; Introns/genetics ; Male ; Nerve Tissue Proteins/genetics ; Nuclear Proteins/genetics ; Nucleotides/genetics ; Phenotype ; Proteins/genetics ; RNA, Small Nucleolar/genetics ; Ribonucleoproteins/genetics ; Ribonucleoproteins, Small Nuclear/genetics ; Ubiquitin-Protein Ligases ; snRNP Core Proteins
References:
Hum Mol Genet. 1994 Feb;3(2):309-15. (PMID: 8004100)
Hum Genet. 2005 Feb;116(3):228-30. (PMID: 15565282)
Nucleic Acids Res. 1995 Jan 25;23(2):256-60. (PMID: 7862530)
Nucleic Acids Res. 1995 Mar 25;23(6):1087-8. (PMID: 7731798)
Nat Genet. 1995 Apr;9(4):395-400. (PMID: 7795645)
Am J Hum Genet. 1996 Feb;58(2):335-46. (PMID: 8571960)
Nat Genet. 1996 Apr;12(4):452-4. (PMID: 8630505)
Hum Mol Genet. 1996 Apr;5(4):517-24. (PMID: 8845846)
Nat Genet. 1997 May;16(1):16-7. (PMID: 9140389)
Hum Mol Genet. 1999 Dec;8(13):2497-505. (PMID: 10556298)
Hum Mol Genet. 2000 Jul 22;9(12):1813-9. (PMID: 10915770)
J Mol Endocrinol. 2000 Oct;25(2):169-93. (PMID: 11013345)
Am J Hum Genet. 2000 Nov;67(5):1067-82. (PMID: 11007541)
Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14311-6. (PMID: 11106375)
J Med Genet. 2001 Jan;38(1):26-34. (PMID: 11134237)
Hum Mol Genet. 2001 Feb 1;10(3):201-10. (PMID: 11159938)
Pediatrics. 2001 Nov;108(5):E92. (PMID: 11694676)
Hum Mol Genet. 2001 Nov 1;10(23):2687-700. (PMID: 11726556)
Cell. 2002 Apr 19;109(2):145-8. (PMID: 12007400)
Exp Hematol. 2002 Jun;30(6):503-12. (PMID: 12063017)
Am J Hum Genet. 2002 Sep;71(3):669-78. (PMID: 12154412)
Cytogenet Genome Res. 2002;97(3-4):158-62. (PMID: 12438706)
Am J Hum Genet. 2003 Mar;72(3):571-7. (PMID: 12545427)
Am J Hum Genet. 2003 Oct;73(4):898-925. (PMID: 14508708)
Nat Genet. 2004 Jan;36(1):40-5. (PMID: 14702039)
N Engl J Med. 1981 Feb 5;304(6):325-9. (PMID: 7442771)
Proc Natl Acad Sci U S A. 1981 Nov;78(11):7033-7. (PMID: 7031667)
J Mol Biol. 1981 Sep 5;151(1):17-33. (PMID: 6276559)
Am J Med Genet. 1991 Oct 1;41(1):64-8. (PMID: 1683160)
Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1827-31. (PMID: 1542678)
N Engl J Med. 1992 Jun 11;326(24):1599-607. (PMID: 1584261)
Pediatrics. 1993 Feb;91(2):398-402. (PMID: 8424017)
Nat Genet. 1992 Dec;2(4):265-9. (PMID: 1303277)
Nat Genet. 1994 Feb;6(2):163-7. (PMID: 7512861)
Am J Hum Genet. 1997 Aug;61(2):388-94. (PMID: 9311744)
Nat Genet. 1997 Nov;17(3):357-61. (PMID: 9354807)
Hum Mol Genet. 1997 Oct;6(11):1873-8. (PMID: 9302265)
Am J Hum Genet. 1999 Jan;64(1):70-6. (PMID: 9915945)
Hum Mol Genet. 1999 May;8(5):783-93. (PMID: 10196367)
Hum Mol Genet. 1999 May;8(5):795-803. (PMID: 10196368)
Proc Natl Acad Sci U S A. 1999 May 11;96(10):5616-21. (PMID: 10318933)
Nat Genet. 1994 Sep;8(1):52-8. (PMID: 7987392)
Grant Information:
R01 HD041623 United States HD NICHD NIH HHS; HD41623 United States HD NICHD NIH HHS
Substance Nomenclature:
0 (Antigens, Neoplasm)
0 (Autoantigens)
0 (MAGEL2 protein, human)
0 (Magel2 protein, mouse)
0 (Nerve Tissue Proteins)
0 (Nuclear Proteins)
0 (Nucleotides)
0 (Proteins)
0 (RNA, Small Nucleolar)
0 (Ribonucleoproteins)
0 (Ribonucleoproteins, Small Nuclear)
0 (SNRPN protein, human)
0 (necdin)
0 (snRNP Core Proteins)
EC 2.3.2.27 (MKRN3 protein, human)
EC 2.3.2.27 (Ubiquitin-Protein Ligases)
Entry Date(s):
Date Created: 20050510 Date Completed: 20050607 Latest Revision: 20201209
Update Code:
20240104
PubMed Central ID:
PMC1142316
DOI:
10.1186/1471-2350-6-18
PMID:
15877813
Czasopismo naukowe
Background: Prader-Willi syndrome (MIM #176270; PWS) is caused by lack of the paternally-derived copies, or their expression, of multiple genes in a 4 Mb region on chromosome 15q11.2. Known mechanisms include large deletions, maternal uniparental disomy or mutations involving the imprinting center. De novo balanced reciprocal translocations in 5 reported individuals had breakpoints clustering in SNRPN intron 2 or exon 20/intron 20. To further dissect the PWS phenotype and define the minimal critical region for PWS features, we have studied a 22 year old male with a milder PWS phenotype and a de novo translocation t(4;15)(q27;q11.2).
Methods: We used metaphase FISH to narrow the breakpoint region and molecular analyses to map the breakpoints on both chromosomes at the nucleotide level. The expression of genes on chromosome 15 on both sides of the breakpoint was determined by RT-PCR analyses.
Results: Pertinent clinical features include neonatal hypotonia with feeding difficulties, hypogonadism, short stature, late-onset obesity, learning difficulties, abnormal social behavior and marked tolerance to pain, as well as sticky saliva and narcolepsy. Relative macrocephaly and facial features are not typical for PWS. The translocation breakpoints were identified within SNRPN intron 17 and intron 10 of a spliced non-coding transcript in band 4q27. LINE and SINE sequences at the exchange points may have contributed to the translocation event. By RT-PCR of lymphoblasts and fibroblasts, we find that upstream SNURF/SNRPN exons and snoRNAs HBII-437 and HBII-13 are expressed, but the downstream snoRNAs PWCR1/HBII-85 and HBII-438A/B snoRNAs are not.
Conclusion: As part of the PWCR1/HBII-85 snoRNA cluster is highly conserved between human and mice, while no copy of HBII-438 has been found in mouse, we conclude that PWCR1/HBII-85 snoRNAs is likely to play a major role in the PWS- phenotype.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies